The body needs time to adjust to incretin-based therapy, and rushing that adjustment period does not accelerate long-term results
Anecdotal reports have also stated a dosage range of 100 to 250mcg for DSIP
The key difference lies in their molecular structure: GHK-Cu contains glycine, histidine, and lysine, whereas AHK-Cu replaces glycine with alanine
These findings contribute towards modality-agnostic, generalizable diagnostic models in stroke
The most intense effects, like dissociation and visual changes, peak around 20-40 minutes into treatment and gradually wear off within 1-2 hours
It is described as a N-terminal acetylated 17-23 fragment of human thymosin beta 4 which is a synthetic version that promotes tissue repair, regeneration, and muscle growth